News About: Pharm. Industry
Green Cross emerges as No. 1 pharmaceutical company in first half
Although Green Cross Corp., which ranked second in terms of revenue last year, its first half revenue jumped 72.9 percent to 447.5 billion won while it earned an operating profit of 109.9 billion won ― 231.8 percent u...
Green Cross to produce once-daily influenza treatment
Green Cross Corp., a Korean drug firm, will market its investigational antiviral drug. Approval was given on August 15 by the Korea Food and Drug Administration (KFDA) for the sales of the intravenous antiviral named ...
Medison, Rwanda government to form joint venture
Medison Co., a local medical device maker, said on August 6 it will establish a joint venture with the Rwanda’s government to manufacture its state-of-art diagnostic ultrasound equipment in East Africa.
Sohn Won-gi...
KPMA likely to support delay of unified distribution system
The board of directors of the Korea Pharmaceutical Manufacturers Association is expected to back the position of local wholesalers to delay the current unified distribution system by 2013, according to market sources....
Ubiquitous healthcare emerging as new growth engine
Some companies affiliated with large businesses, including Samsung SDS, LG CNS and SK C&C, are forging ahead with their ambitious plans of converging telecom services with associated businesses with associated healthc...
Drugmakers express concerns over wholesaling salesperson’s embezzlement
Many domestic pharmaceutical manufacturers have expressed concerns over wholesaling salesperson’s misappropriation of official money, calling it "too frequent," sources said recently.
Against this backdrop, pharmac...
SK Chemicals advocates vaccine security
When the influenza A (H1N1) fear swept the world last year, Koreans were relieved over the domestic availability of vaccines. Green Cross Korea produced the vaccine "Green Flu S" in December.
This time, SK Chemical...
Novartis Korea joins smartphone bandwagon
With smartphones finally going mass market, Novartis Korea said it has initiated its smartphone game application service “Lamisil, breaker for Trichophyton mentagrophytes” from August 10.
As smartphones work more l...
KPMA to discuss unified distribution issue
The Korea Pharmaceutical Manufacturers Association will decide to clarify its position to the controversial unified distribution issue on August 13, according to the informed sources.
Most of the KPMA members are p...
Choong-wae, Fujirebio sign agreement over Lumipulse G1200
Choongwae-Pharm announced on August 11 that it has signed an exclusive distribution agreement with Fujirebio Diagnostics, Inc. of Japan to distribute the latter’s diagnostic agent “Lumipulse G1200.”
Lumipulse G120...
